$14.71
0.634.47%
Pre-Market: 7:38 PM EDT
Comments
Loading...
ARS Pharmaceuticals (NASDAQ:SPRY) Stock, Earnings Estimates, EPS, And Revenue
ARS Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.200
Quarterly Revenue
$2.1M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$500K
Analyze the earnings history of ARS Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
ARS Pharmaceuticals (SPRY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $-0.20 | $-0.15 | -33.3 % |
| Jun 2024 | 2024-08-06 | $-0.13 | $-0.12 | -8.33 % |
| Mar 2024 | 2024-05-09 | $-0.11 | $-0.11 | 0.00 % |
| Dec 2023 | 2024-03-21 | $-0.07 | $-0.14 | 50.0 % |
ARS Pharmaceuticals (SPRY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-13 | $2.07M | $560.00K | 269.3 % |
| Jun 2024 | 2024-08-06 | $500.00K | $1.00M | -50.0 % |
FAQ
When is ARS Pharmaceuticals (NASDAQ:SPRY) reporting earnings?
ARS Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for ARS Pharmaceuticals (NASDAQ:SPRY)?
ARS Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.20, which missed the estimate of $-0.15.
What were ARS Pharmaceuticals’s (NASDAQ:SPRY) revenues?
ARS Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.